🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Contribution of Point of Care Ultrasound by the Emergency Physician to Rule Out the Small Bowel Obstruction: a Diagnostic, Multicenter Study

Recruitingn/aAges 18 Years - anyAllNantes University Hospital
NCT06803628 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Small Bowel Obstruction (SBO) is a frequent pathology in the emergency department (ED). Diagnosis is currently based on abdominal CT scan (CT). Moreover, CT is warranted to determine the therapeutic strategy in patients with SBO which could include medical treatment; surgical intervention or both. However, CT is associated with drawbacks such as radiation exposure, increased cost and ED length-of-stay. In a prospective observational study, a SBO was excluded by CT in 45% \[95%CI: 37-53\] of patients. There is, thus, a need for improving the appropriateness of CT-scan for suspected SBO. A recent meta-analysis showed that Point of care ultrasound (POCUS) had a good diagnostic accuracy (sensitivity 83% \[95%CI 71.7%-90.4%\]), specificity 93% \[95%CI 55.3%-99.3%\]). Another meta-analysis found rather similar results (sensitivity 83% \[(95% CI 89.0% to 94.7%\], specificity 96,6% \[95% CI 88

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Major patient (age \> 18 years old), no upper limit 2. Patient admitted to the ED with suspected SBO (abdominal pain, vomiting, cessation of gas and feces...) 3. Low or moderate pretest Gestalt clinical probability 4. Patient able to understand protocol and express agreement 5. Oral non-opposition given Exclusion Criteria: 1. Patient under legal guardianship 2. Pregnant women 3. Nursing mothers 4. Patient who does not speak or understand French 5. Patient without a health insurance plan 6. Patient who already had imaging confirming the diagnosis 7. Patient who participates simultaneously in any interventional study focused on abdominal pain before POCUS and CT realization
💊

What it tests

  • Point of care ultrasound
📍

Where

18 sites
Chu Clermont-Ferrand Hopital Gabriel Montpied
Clermont-Ferrand, France
Ghem Groupe Hospitalier Eaubonne Montmorency Simone Veil
Eaubonne, France
CHD Vendée
La Roche-sur-Yon, France
CHD Vendée, Luçon
Luçon, France
Ap-Hm Hopital La Timone
Marseille, France
Hôpital Nord
Marseille, France
Ghsif Groupe Hospitalier Sud Ile de Franc _ Ch Melun
Melun, France
CHD Vendée, Montaigu
Montaigu, France

…and 10 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy